Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-000789
Accepted
2025-03-27 00:15:12
Documents
1
Effectiveness Date
2025-03-26

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 598
  Complete submission text file 9999999995-25-000789.txt   2028
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-280993 | Film No.: 25774986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)